China’s investment in innovation is fostering scientific and technological advances. Jin Liwang/Xinhua via Getty Images

    China surpasses US in research spending

    China’s rapid rise in science has hit a milestone. The country’s investment in research and development has reached parity with – and by purchasing power measures has surpassed – that of the United States, according to a March 2026 report from the Organisation for Economic Co-operation and Development. Both nations have crossed the US$1 trillion…

    Read More
    China Just Surpassed the US in Research Spending and it Could Cost America a Trillion Dollars Over the Next Decade

      China Just Surpassed the US in Research Spending and it Could Cost America a Trillion Dollars Over the Next Decade

      Credit: ZME Science. China’s rapid rise in science has hit a milestone. The country’s investment in research and development has reached parity with – and by purchasing power measures has surpassed – that of the United States, according to a March 2026 report from the Organisation for Economic Co-operation and Development. Both nations have crossed…

      Read More
      STAT+

        China’s rapid ascent is reshaping drug development

        Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The NIH’s foreign subaward crackdown is scrambling global collaborations, while China’s rapid ascent is reshaping drug development. Meanwhile, Wave Life Sciences sheds half its value on underwhelming obesity results. Also, breaking: I’m adopting a rogue…

        Read More
        A two-story interior with many windows features a mural with the word “Pyrotech” and a logo of 10 circles arranged in a circle.

          How Chinese labs race for the next ‘first-in-class’ breakthrough

            Key Insights China’s researchers are racing to close the country’s gap with the US in chemistry-related advancements and secure the next frontier of innovations in materials, energy, and biomedicine. Increasing funding pools, investments in health-system reforms, and innovation-driven policies, such as integrating medical insurance data into R&D, are accelerating the rate of China’s gain in developing novel drugs, according…

          Read More
          STAT+

            China biopharma, JP Morgan 2026: Readout Newsletter

            Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game this Saturday. Going into JPM, it’s good to be a…

            Read More